光AI向FDA申请批准一种预测烧伤愈合的AI工具. Spectral AI applies to the FDA for approval of an AI tool that predicts burn wound healing.

谱AI向FDA提交了其DeepView系统的申请,该系统是一种使用人工智能和多谱成像预测伤口愈合的非侵入性烧伤护理工具. Spectral AI has submitted an application to the FDA for its DeepView System, a non-invasive burn care tool using AI and multi-spectral imaging to predict wound healing. 这份来文寻求De Novo市场营销许可,目的是向医生提供评估烧伤预测和作出治疗决定的新方法。 This submission seeks De Novo marketing clearance, aiming to offer doctors a new method for assessing burn wound prognosis and making treatment decisions. 该系统之前已获得FDA的突破性设备指标. The system has previously received Breakthrough Device Designation from the FDA.